- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
- Introducing in vivo pancreatic cancer models for the study of new therapeutic regimens2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma2021 | First Faculty of Medicine
- Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options2015 | Second Faculty of Medicine
- 3,5,7-Substituted Pyrazolo[4,3-d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders2022 | First Faculty of Medicine, Central Library of Charles University
- 3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models2019 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL2017 | First Faculty of Medicine
- mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma2023 | First Faculty of Medicine, Third Faculty of Medicine
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | Second Faculty of Medicine, First Faculty of Medicine
- Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma2020 | Second Faculty of Medicine, First Faculty of Medicine
- YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells are Regulated by LCK and Independent of LATS Activity2018 | Publication without faculty affiliation
- Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate2019 | Central Library of Charles University
- Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma2018 | Faculty of Medicine in Hradec Králové
- Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells2020 | Second Faculty of Medicine, First Faculty of Medicine
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine
- Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative2017 | First Faculty of Medicine
- Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML2021 | First Faculty of Medicine